Position in ALKS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$494,608
+$160,845 QoQ
Shares Held
9,440
+0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#241
of 421 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ashton Thomas Private Wealth, LLC holds $3,513,130 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
14,915 | $1,654,670 | |
| 2 | ALKS |
Alkermes plc.
This page
|
9,440 | $494,608 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
10,537 | $432,333 | |
| 4 | ZTS |
Zoetis Inc.
|
5,086 | $365,479 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
3,971 | $328,719 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
438 | $237,321 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $494,608 | 9,440 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $333,763 | 9,439 | Shares | Sole | 2026-05-11 | |
| 2025-03-31 | $212,846 | 6,446 | Shares | Sole | 2025-05-16 | |
| 2024-06-30 | $115,969 | 4,812 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||